Clinical Trials Browser

Phase 1 × Temozolomide × Dermatologic × Clear all

NCT01005472 2020-08-03

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT00527657 2018-11-14

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Phase 1 Completed

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00526617 2017-11-21

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Phase 1 Completed

BreastDermatologicGastrointestinalGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms

NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Phase 1 Withdrawn

DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT01067066 2017-07-21

A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma

Phase 1 Terminated

Melanoma

NCT01409174 2017-05-31

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Phase 1 Terminated

Melanoma, Neoplasm Metastasis

NCT01127594 2015-03-09

Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion

Phase 1 Completed

Melanoma

NCT00003747 2013-09-20

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00016055 2013-09-20

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00970996 2013-01-03

BCAA

Phase 1 Completed

Melanoma

NCT01294735 2012-08-15

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Phase 1 Completed

CNSDermatologic

Glioblastoma, Melanoma

NCT00527761 2012-07-30

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

Phase 1 Completed

Melanoma

NCT00629187 2012-04-27

CN-306

Phase 1 Terminated

BreastCNSDermatologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Central Nervous System Neoplasms, Neoplasms, Second Primary

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Phase 1 Unknown

Melanoma

NCT00272415 2009-03-11

A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma

Phase 1 Terminated

Deafness, Autosomal Recessive 53, Melanoma